Sarah J. Bartulis

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.

Simon Ng, Yanchen Zhang, Kenneth Crawford, 2011, ACS medicinal chemistry letters.

Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice.

C. Weber, J. Messer, L. Rhee, 2014, American journal of physiology. Gastrointestinal and liver physiology.

TNFAIP3 Maintains Intestinal Barrier Function and Supports Epithelial Cell Tight Junctions

Xiaorong Zhu, J. Messer, J. Turner, 2011, PloS one.

The Crohn's disease: associated ATG16L1 variant and Salmonella invasion

J. Messer, W. A. Grimm, J. Lodolce, 2013, BMJ Open.

The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon

M. Bissonnette, D. Huo, N. Ellis, 2015, Gut.

African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity

E. Adams, S. Hanauer, N. Ellis, 2010, The Journal of Immunology.

Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.

Shirley C. Paski, C. Weber, J. Messer, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors.

E. Iwanowicz, Z. Ni, T. Hendrickson, 2011, ACS medicinal chemistry letters.